PATANOL

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Ecuador, Israel, Japan, Mexico, New Zealand, Singapore, South Africa, Turkey.

Active ingredients

The drug PATANOL contains one active pharmaceutical ingredient (API):

1	Olopatadine UNII 2XG66W44KF - OLOPATADINE HYDROCHLORIDE
	Olopatadine is a potent selective antiallergic/antihistaminic agent that exerts its effects through multiple distinct mechanisms of action.
	Read more about Olopatadine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PATANOL Eye drops, solution	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01GX09	Olopatadine	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500903101175310, 500904601171411
CA	Health Products and Food Branch	02233143
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.610-03-04, 28554-09-08
IL	מִשְׂרַד הַבְּרִיאוּת	4866
JP	医薬品医療機器総合機構	1319752Q1024
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	463M98
NZ	Medicines and Medical Devices Safety Authority	10163
SG	Health Sciences Authority	10485P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504612073
US	FDA, National Drug Code	0065-0271
ZA	Health Products Regulatory Authority	33/15.4/0189